CVTOX
- Product NDC
- 43857-0391
- Requested package NDC
- 43857-0391-1
- 11-digit product format
- 438570391
- Labeler code
- 43857
- Product ID
- 43857-0391_9577308f-505d-4f1d-8565-4881ba5da1df
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cochlearia Armoracia, Echinacea (Angustifolia), Lomatium Dissectum, Tabebuia Impetiginosa, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Bovine, Thymus (Suis), Aranea Diadema, Ipecacuanha, Lycopodium Clavatum, Muriaticum Acidum, Nitricum Acidum, Phosphoricum Acidum, Rhus Tox, Silicea, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Herpes Zoster Nosode, Morbillinum, Poliomyelitis Nosode, Hepatitis B Nosode, Coxsackie B1 Nosode, Coxsackie B4 Nosode
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- BioActive Nutritional, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2016-05-02
- Marketing end
- 2023-08-27
- Substance
- HORSERADISH; ECHINACEA ANGUSTIFOLIA; LOMATIUM DISSECTUM ROOT; TABEBUIA IMPETIGINOSA BARK; GOLDENSEAL; PROPOLIS WAX; BOS TAURUS ADRENAL GLAND; SUS SCROFA THYMUS; ARANEUS DIADEMATUS; IPECAC; LYCOPODIUM CLAVATUM SPORE; HYDROCHLORIC ACID; NITRIC ACID; PHOSPHORIC ACID; TOXICODENDRON PUBESCENS LEAF; SILICON DIOXIDE; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 3; MEASLES VIRUS; POLIOVIRUS; HEPATITIS B VIRUS; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4
- Active strength
- 3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 43857-0391 | 43857-0391-1 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 43857-0391-1 | 43857039101 | 30 mL in 1 BOTTLE, DROPPER (43857-0391-1) | 30 ml | 2016-05-02 | 2023-08-27 | No | No | Current |